Our news

06 May 2022

Launching RiboLace XL

fast and flexible solution to isolate active ribosomes for ribosome profiling experiments

24 January 2022

RiboOmics Grant Challenge 2021 - Winners announcement

RiboOmics Award acknowledges research achievements and cutting-edge projects by top-young scientists in the growing areas of ribosome analysis. With RiboOmics we support scientists outside conventional streamflow.

12 January 2022

Press News: IMMAGINA BIOTECHNOLOGY

Immagina Biotechnology: nuova sede a Pergine Valsugana

11 January 2022

Immagina Biotechnology: nuova sede a Pergine Valsugana nel sito Areaderma

Doppia operazione immobiliare condotta da Trentino Sviluppo, d’intesa con la Provincia autonoma di Trento, per sostenere i piani di crescita di imprese trentine dall’elevato tasso di innovazione: l’azienda di cosmetica Areaderma e Immagina Biotechnology.

11 January 2022

Immagina Biotechnology: new headquarters in Pergine Valsugana (english)

mmagina, the world’s #1 RibosomeCompany, today announced the agreement with the local innovation agency to relocate to our own 1500 m2 new headquarter to meet the growing demand from our customers and collaborators.

01 December 2021

New IMMAGINA publication: Phospho-RNA sequencing with circAID-p-seq

An original method for 3′-P/cP RNA-seq library preparation and the first selective 3′-phospho RNA sequencing

18 November 2021

Autumn 2021 Company Retreat

Fri Nov 19th- Sat Nov 20th, 2021- We had a great company retreat in Merano (Italy) with all Immagina team. We are getting bigger and stronger very fast!!!

04 November 2021

Immagina Ribo-Omics Grant Challenge 2021

Immagina Biotech announces today a new edition of its RiboOmics Grant Challenge in 2021 supporting cutting edge research projects to study ribosome function, regulation of translation and translatome.

20 May 2021

IMMAGINA Company Retreat

May 20th 2021 we had a constructive 1-day company retreat in Riva del Garda (Italy).

01 May 2021

New publication citing AHARIBO

Ali Bayoumi, (The Westmead Institute for Medical Research) et al., measured protein associated with translationally active ribosomes using AHARIBO kits. Congratulations on the great work!

26 March 2021

Co-Author in Book Chapter: Ribosome Profiling: Methods and Protocols

Massimiliano Clamer and scientific advisor Gabriella Viero co-author in Ribosome Profiling: Methods and Protocols, under book chapter 9. Active Ribosome Profiling with RiboLace: From Bench to Data Analysis

17 February 2021

Our new paper published

On detection of ribosome-associated lncRNA

12 January 2021

Video for IMMAGINA Technology for Students Out

Self-explanatory video for students describing the three main technologies developed by IMMAGINA to enable scientists to achieve their highest scientific objectives.

16 December 2020

IMMAGINA on Nanopore News!

Based on the paper: Phospho-RNA sequencing with CircAID-p-seq

16 December 2020

New technology out!

We are proud to present circAID-p-seq: an original and unique method for 3′-P/cP RNA-seq library preparation.

14 December 2020

Client Testimonial

Scott Lindner, Associate Professor of Biochemistry & Molecular Biology, Co-Director, Center for Malaria Research at Pennsylvania State University

01 November 2020

New Distribution Agreement

Immagina Biotech and Tri-I Biotech announce distribution agreement

21 September 2020

New Nature Publication

SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy

01 September 2020

EIT Headstart Grant

Grant awarded to investigate circAID-p-seq applications in the pharmaceuticals sector

01 September 2020

Ribo-Omics Grant Challenge 2020

Discover the Winners of our Ribo-Omics Grant Challenge

01 July 2020

Online webinar: Spinal Muscular Atrophy: Lost in Translation? by Gabriella Viero PhD, Researcher at Institute of Biophysics, CNR Unit, Trento

Join us for our free live scientific webinars!

01 May 2020

IMMAGINA RNA2020 Poster

One-shot analysis of translated mammalian lncRNAs with AHARIBO

01 March 2020

Announcing our collaboration with Genexa!

We are working together to develop a powerful data analysis tool for the only product available for 3’ phospho-RNA sequencing with the ONT sequencing platform, circAID-p-seq!

01 February 2020

IMMAGINA Raises 1M €

In February 2020 IMMAGINA BioTechnology raised 1M Euro from existing investors and new, undisclosed EU-based investors. The Company has raised about 2M Euro to date.

20 December 2018

New scientific publication: phospho-RNA sequencing with CircAID-p-seq

IMMAGINA BioTechnology presents circAID-p-seq phospho-RNA sequencing kit